ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

UC Davis Comprehensive Cancer Center at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

UC Davis Comprehensive Cancer Center takes part in 3 sessions at ESMO 2026 in Madrid. Its work spans lung cancer biomarkers, treatment resistance and patient-reported outcomes. It examines genetic changes in lung tumors and resistance to firmonertinib, alongside outcomes in small cell lung cancer.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
Comprehensive cancer center of the University of California, Davis, providing cancer care in Sacramento, CA.
Satellite
Sun Oct 25
18:50–19:10
How Do Patient-Reported Outcomes Shape Clinical Decisions?
Regeneron - From Voice to Value: Advancing Actionable Patient- Reported Outcomes Evidence in Oncology
Nursing & supportive care
Poster
Mon Oct 26
12:00–12:45
Genomic and biomarker landscape of MTAP loss/KRAS G12D mutant vs. MTAP loss/KRAS non-mutated advanced NSCLC
Monday Poster Display session 5
Lung & thoracic cancersBiomarkers & precision oncology
Poster
Mon Oct 26
12:00–12:45
Abstract
Mon Oct 26
14:55–15:05
3809O - Randomized trial of serplulimab or atezolizumab plus chemotherapy in USA patients with extensive-stage small cell lung cancer (ASTRIDE)
Proffered paper: Non-metastatic NSCLC and other thoracic malignancies
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at UC Davis Comprehensive Cancer Center

Tell us what you sell and we’ll find the people at UC Davis Comprehensive Cancer Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction